Bruce Thompson, Kincell Bio CEO

Ex­clu­sive: Cell ther­a­py CD­MO Kin­cell launch­es, and the spin­out is val­ued at $66M, with CEO look­ing for carve-outs

A small CD­MO called Kin­cell Bio launched Wednes­day, with its CEO hop­ing to fill a niche of­fer­ing cell ther­a­py man­u­fac­tur­ing for ear­ly-stage biotech star­tups. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA